A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand

[1]  N. White,et al.  The de novo selection of drug–resistant malaria parasites , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[2]  A. Mr.  Severe and complicated malaria. , 2002 .

[3]  N. White,et al.  Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[4]  Richard N. Price,et al.  Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study , 2000, The Lancet.

[5]  N. White,et al.  Pharmacokinetics and Pharmacodynamics of Lumefantrine (Benflumetol) in Acute Falciparum Malaria , 2000, Antimicrobial Agents and Chemotherapy.

[6]  N. White,et al.  Delaying antimalarial drug resistance with combination chemotherapy. , 1999, Parassitologia.

[7]  N. White,et al.  Clinical Pharmacokinetics and Pharmacodynamics of Artemether-Lumefantrine , 1999 .

[8]  T. Jelínek,et al.  Population structure of recrudescent Plasmodium falciparum isolates from Western Uganda , 1999, Tropical medicine & international health : TM & IH.

[9]  N. White,et al.  Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. , 1999, The American journal of tropical medicine and hygiene.

[10]  R. Price,et al.  Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. , 1999, The American journal of tropical medicine and hygiene.

[11]  J. Karbwang,et al.  Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. , 1998, British journal of clinical pharmacology.

[12]  W. Wernsdorfer,et al.  Activity of benflumetol and its enantiomers in fresh isolates of Plasmodium falciparum from East Africa. , 1998, Acta tropica.

[13]  P. Leggat,et al.  Consensus recommendation on the treatment of malaria in Southeast Asia. , 1998, The Southeast Asian journal of tropical medicine and public health.

[14]  N. White,et al.  Assessment of the pharmacodynamic properties of antimalarial drugs in vivo , 1997, Antimicrobial agents and chemotherapy.

[15]  H. Webster,et al.  The epidemiology of malaria in a Karen population on the western border of Thailand. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[16]  J. Karbwang,et al.  Clinical application of mefloquine pharmacokinetics in the treatment of P falciparum malaria , 1994, Fundamental & clinical pharmacology.

[17]  N. White,et al.  Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. , 1994, The Journal of infectious diseases.

[18]  N. White,et al.  Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  H. Webster,et al.  Mefloquine-resistant falciparum malaria on the Thai-Burmese border , 1991, The Lancet.

[20]  Horace K. Gifpen.  The American Journal of Tropical Medicine and Hygiene , 1952 .

[21]  F. Nosten,et al.  Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. , 1999, The American journal of tropical medicine and hygiene.

[22]  Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.